These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 37604303)

  • 21. Changes in opioid prescribing after implementation of mandatory registration and proactive reports within California's prescription drug monitoring program.
    Castillo-Carniglia A; González-Santa Cruz A; Cerdá M; Delcher C; Shev AB; Wintemute GJ; Henry SG
    Drug Alcohol Depend; 2021 Jan; 218():108405. PubMed ID: 33234299
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The prescription drug monitoring program in a multifactorial approach to the opioid crisis: PDMP data, Pennsylvania, 2016-2020.
    Adalbert JR; Syal A; Varshney K; George B; Hom J; Ilyas AM
    BMC Health Serv Res; 2023 Apr; 23(1):364. PubMed ID: 37046254
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of a Mandatory Prescription Drug Monitoring Program Check on Emergency Department Opioid Prescribing Rates.
    Watson CJ; Ganetsky M; Burke RC; Dizitzer Y; Leventhal EL; Boyle KL
    J Med Toxicol; 2021 Jul; 17(3):265-270. PubMed ID: 33821434
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of State Opioid Prescribing Laws on Use of Opioid and Other Pain Treatments Among Commercially Insured U.S. Adults.
    McGinty EE; Bicket MC; Seewald NJ; Stuart EA; Alexander GC; Barry CL; McCourt AD; Rutkow L
    Ann Intern Med; 2022 May; 175(5):617-627. PubMed ID: 35286141
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Accuracy and validity of reported opioid prescription days' supply.
    Miracle DK; Slavova S; Brown JR; Dasgupta N; Harris S; Freeman PR
    Pharmacoepidemiol Drug Saf; 2022 Dec; 31(12):1253-1261. PubMed ID: 36053913
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Controlled Substance Prescribing Patterns--Prescription Behavior Surveillance System, Eight States, 2013.
    Paulozzi LJ; Strickler GK; Kreiner PW; Koris CM;
    MMWR Surveill Summ; 2015 Oct; 64(9):1-14. PubMed ID: 26469747
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High-Risk Opioid Prescribing Trends: Prescription Drug Monitoring Program Data From 2010 to 2018.
    Ball SJ; Simpson K; Zhang J; Marsden J; Heidari K; Moran WP; Mauldin PD; McCauley JL
    J Public Health Manag Pract; 2021 Jul-Aug 01; 27(4):379-384. PubMed ID: 32956292
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of a prescription drug monitoring program use mandate on potentially problematic patterns of opioid analgesic prescriptions in New York City.
    Bachhuber MA; Tuazon E; Nolan ML; Kunins HV; Paone D
    Pharmacoepidemiol Drug Saf; 2019 May; 28(5):734-739. PubMed ID: 30920062
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Has a Prescription-limiting Law in Rhode Island Helped to Reduce Opioid Use After Total Joint Arthroplasty?
    Reid DBC; Shapiro B; Shah KN; Ruddell JH; Cohen EM; Akelman E; Daniels AH
    Clin Orthop Relat Res; 2020 Feb; 478(2):205-215. PubMed ID: 31389888
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association Between State Opioid Prescribing Cap Laws and Receipt of Opioid Prescriptions Among Children and Adolescents.
    Stone EM; Tormohlen KN; McCourt AD; Schmid I; Stuart EA; Davis CS; Bicket MC; McGinty EE
    JAMA Health Forum; 2022 Aug; 3(8):e222461. PubMed ID: 36003417
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Effect of Opioid Prescribing Guidelines on Prescriptions by Emergency Physicians in Ohio.
    Weiner SG; Baker O; Poon SJ; Rodgers AF; Garner C; Nelson LS; Schuur JD
    Ann Emerg Med; 2017 Dec; 70(6):799-808.e1. PubMed ID: 28549620
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characteristics of statewide prescription drug monitoring programs and potentially inappropriate opioid prescribing to patients with non-cancer chronic pain: A machine learning application.
    Lin HC; Wang Z; Hu YH; Simon K; Buu A
    Prev Med; 2022 Aug; 161():107116. PubMed ID: 35750263
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of Florida's Prescription Drug Monitoring Program and Pill Mill Laws on Opioid Prescribing and Use.
    Rutkow L; Chang HY; Daubresse M; Webster DW; Stuart EA; Alexander GC
    JAMA Intern Med; 2015 Oct; 175(10):1642-9. PubMed ID: 26280092
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prescription Drug Monitoring Programs Are Associated With Sustained Reductions In Opioid Prescribing By Physicians.
    Bao Y; Pan Y; Taylor A; Radakrishnan S; Luo F; Pincus HA; Schackman BR
    Health Aff (Millwood); 2016 Jun; 35(6):1045-51. PubMed ID: 27269021
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Decrease in Urologic Discharge Opioid Prescribing after Mandatory Query of Statewide Prescription Drug Monitoring Program.
    Myrga JM; Macleod LC; Bandari J; Jacobs BL; Davies BJ
    Urology; 2020 May; 139():84-89. PubMed ID: 32061826
    [TBL] [Abstract][Full Text] [Related]  

  • 36. State pain management clinic policies and county opioid prescribing: A fixed effects analysis.
    Frizzell LC; Vuolo M; Kelly BC
    Drug Alcohol Depend; 2020 Nov; 216():108239. PubMed ID: 32854001
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluating Emergency Department Opioid Prescribing Behaviors After Education About Mandated Use of the Pennsylvania Prescription Drug Monitoring Program.
    Martello J; Cassidy B; Mitchell A
    J Addict Nurs; 2018; 29(3):196-202. PubMed ID: 30180006
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An Examination of Concurrent Opioid and Benzodiazepine Prescribing in 9 States, 2015.
    Guy GP; Zhang K; Halpin J; Sargent W
    Am J Prev Med; 2019 Nov; 57(5):629-636. PubMed ID: 31564606
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Provider Prescription Drug Monitoring Program Utilization and Self-Auditing-A Pilot Study.
    Brown WC; Whitted K
    J Dr Nurs Pract; 2020 Jul; 13(2):142-147. PubMed ID: 32817503
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of Opioid Prescription Policy on Overdoses and Related Adverse Effects in a Primary Care Population.
    Harder VS; Plante TB; Koh I; Rogers EB; Varni SE; Villanti AC; Brooklyn JR; Fairfield KM
    J Gen Intern Med; 2021 Jul; 36(7):2013-2020. PubMed ID: 33948793
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.